Latest News & Features
article
The firm has strengthened its Sheffield office with a senior patent attorney who joins from GlaxoSmithKline. 25 October 2022
Big Pharma
The deal sees Sumitomo acquiring ownership of cancer and uterine fibroid treatments | Myovant initially rejected low offer that “undervalued” the company. 25 October 2022
Americas
The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling. 24 October 2022
Big Pharma
Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed Ventria's rice seed patent | Dispute concerns recombinant human proteins derived from genetically engineered rice. 20 October 2022
Americas
Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical. 20 October 2022
Big Pharma
Gilead will have an exclusive licence and will pay MacroGenics $60 million upfront | Deal includes tiered, double-digit royalties on worldwide net sales. 18 October 2022
Biotechnology
Arbitration panel awarded the sum to Acorda to cover past royalties and interest | Acorda can now source the multiple sclerosis drug elsewhere. 18 October 2022
Big Pharma
The scientist-turned IP specialist chats to LSIPR about why she ‘loves’ the IP sector, her views on policy and funding in science and research, and the cases she’s most proud of. 13 October 2022
Big Pharma
Nexus raises second complaint against same parties in a month | Ready-to-use drug that can raise the blood pressure of hypotension patients at issue. 13 October 2022
Europe
European Commission says pharma firm blocked generics over blockbuster MS drug| Teva “engaged in abusive conduct” to “artificially prolong the exclusivity” of Copaxone | Teva could be found to have infringed Article 102 of TFEU. 11 October 2022